These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28951861)

  • 21. Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
    Leder BZ; O'Dea LS; Zanchetta JR; Kumar P; Banks K; McKay K; Lyttle CR; Hattersley G
    J Clin Endocrinol Metab; 2015 Feb; 100(2):697-706. PubMed ID: 25393645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on bone mass after eight years of hormonal replacement therapy.
    Eiken P; Nielsen SP; Kolthoff N
    Br J Obstet Gynaecol; 1997 Jun; 104(6):702-7. PubMed ID: 9197874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
    Miller PD; Chines AA; Christiansen C; Hoeck HC; Kendler DL; Lewiecki EM; Woodson G; Levine AB; Constantine G; Delmas PD
    J Bone Miner Res; 2008 Apr; 23(4):525-35. PubMed ID: 18072873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
    Brixen K; Chapurlat R; Cheung AM; Keaveny TM; Fuerst T; Engelke K; Recker R; Dardzinski B; Verbruggen N; Ather S; Rosenberg E; de Papp AE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):571-80. PubMed ID: 23337728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of whole body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
    Oliveira LC; Oliveira RG; Pires-Oliveira DA
    Osteoporos Int; 2016 Oct; 27(10):2913-33. PubMed ID: 27145947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
    J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women.
    Jürimäe J; Jürimäe T; Leppik A; Kums T
    J Bone Miner Metab; 2008; 26(6):618-23. PubMed ID: 18979162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
    Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
    Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of fennel vaginal cream on sexual function in postmenopausal women: A double blind randomized controlled trial.
    Abedi P; Najafian M; Yaralizadeh M; Namjoyan F
    J Med Life; 2018; 11(1):24-28. PubMed ID: 29696061
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.
    Jamal SA; Hamilton CJ; Eastell R; Cummings SR
    JAMA; 2011 Feb; 305(8):800-7. PubMed ID: 21343579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosis.
    Orr-Walker B; Wattie DJ; Evans MC; Reid IR
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):87-92. PubMed ID: 9059563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
    Bonnick S; De Villiers T; Odio A; Palacios S; Chapurlat R; DaSilva C; Scott BB; Le Bailly De Tilleghem C; Leung AT; Gurner D
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
    Johnston CC; Bjarnason NH; Cohen FJ; Shah A; Lindsay R; Mitlak BH; Huster W; Draper MW; Harper KD; Heath H; Gennari C; Christiansen C; Arnaud CD; Delmas PD
    Arch Intern Med; 2000 Dec 11-25; 160(22):3444-50. PubMed ID: 11112238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Fennel on the Health Status of Menopausal Women: A Systematic and Meta-analysis.
    Khadivzadeh T; Najafi MN; Kargarfard L; Ghazanfarpour M; Dizavandi FR; Khorsand I
    J Menopausal Med; 2018 Apr; 24(1):67-74. PubMed ID: 29765930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Foeniculum vulgare (fennel) on symptoms of depression and anxiety in postmenopausal women: a double-blind randomised controlled trial.
    Ghazanfarpour M; Mohammadzadeh F; Shokrollahi P; Khadivzadeh T; Najaf Najafi M; Hajirezaee H; Afiat M
    J Obstet Gynaecol; 2018 Jan; 38(1):121-126. PubMed ID: 28891367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : a single-blind randomized, placebo-controlled trial.
    Ye YB; Tang XY; Verbruggen MA; Su YX
    Eur J Nutr; 2006 Sep; 45(6):327-34. PubMed ID: 16763748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
    Lydeking-Olsen E; Beck-Jensen JE; Setchell KD; Holm-Jensen T
    Eur J Nutr; 2004 Aug; 43(4):246-57. PubMed ID: 15309425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
    Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.